MAOB and Alzheimer disease: Federally funded Alzheimer’s disease centers (an unpublished trial) previously reported that the intake of vitamin E (2000 units/day) and/or selegiline (deprenyl, a MAO-B inhibitor; 10 mg/day) has a slowing effect on AD progression [214].